Evolent Health (EVH) Short term Debt (2020 - 2025)
Evolent Health's quarterly Short term Debt came in at $5.1 million in Q3 2025, down 97.03% quarter-over-quarter from $172.1 million in Q2 2025.
Evolent Health has reported Short term Debt for 5 years, with the latest figure at $5.1 million in Q3 2025.
- For the quarter ending Q3 2025, Short term Debt changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Sep 2025 stood at $5.1 million (changed N/A YoY), and the FY2024 full-year result was $171.5 million, changed N/A from the prior year.
- Short term Debt for Q3 2025 stood at $5.1 million, down from $172.1 million in the prior quarter.
- The five-year high for Short term Debt was $172.1 million in Q2 2025, with the low at $991000.0 in Q3 2023.
- Average Short term Debt over 4 years is $75.2 million, with a median of $26.7 million recorded in 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Evolent Health | 467.76 Mn | 301.79 Mn | 83.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 172.12 Mn |
| Mar 31, 2025 | 171.79 Mn |
| Dec 31, 2024 | 171.47 Mn |
| Sep 30, 2023 | 991,000.00 |
| Sep 30, 2021 | 26.70 Mn |
| Jun 30, 2021 | 26.66 Mn |
| Mar 31, 2021 | 26.61 Mn |
| Dec 31, 2020 | 26.56 Mn |